These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 32878800

  • 1. Antitumor Effect of Shikonin, a PKM2 Inhibitor, in Cholangiocarcinoma Cell Lines.
    Thonsri U, Seubwai W, Waraasawapati S, Wongkham S, Boonmars T, Cha'on U, Wongkham C.
    Anticancer Res; 2020 Sep; 40(9):5115-5124. PubMed ID: 32878800
    [Abstract] [Full Text] [Related]

  • 2. TRAIL Enhances Shikonin Induced Apoptosis through ROS/JNK Signaling in Cholangiocarcinoma Cells.
    Zhou G, Yang Z, Wang X, Tao R, Zhou Y.
    Cell Physiol Biochem; 2017 Sep; 42(3):1073-1086. PubMed ID: 28662515
    [Abstract] [Full Text] [Related]

  • 3. PKM2 Inhibitor Shikonin Overcomes the Cisplatin Resistance in Bladder Cancer by Inducing Necroptosis.
    Wang Y, Hao F, Nan Y, Qu L, Na W, Jia C, Chen X.
    Int J Biol Sci; 2018 Sep; 14(13):1883-1891. PubMed ID: 30443191
    [Abstract] [Full Text] [Related]

  • 4. Low levels of pyruvate induced by a positive feedback loop protects cholangiocarcinoma cells from apoptosis.
    Zhang M, Pan Y, Tang D, Dorfman RG, Xu L, Zhou Q, Zhou L, Wang Y, Li Y, Yin Y, Kong B, Friess H, Zhao S, Wu JL, Wang L, Zou X.
    Cell Commun Signal; 2019 Mar 12; 17(1):23. PubMed ID: 30866966
    [Abstract] [Full Text] [Related]

  • 5. PKM2 inhibitor shikonin suppresses TPA-induced mitochondrial malfunction and proliferation of skin epidermal JB6 cells.
    Li W, Liu J, Zhao Y.
    Mol Carcinog; 2014 May 12; 53(5):403-12. PubMed ID: 23255458
    [Abstract] [Full Text] [Related]

  • 6. Knockdown of cullin 3 inhibits progressive phenotypes and increases chemosensitivity in cholangiocarcinoma cells.
    Pratummanee K, Kerdkumthong K, Roytrakul S, Tantimetta P, Runsaeng P, Saeheng S, Obchoei S.
    Mol Med Rep; 2024 Nov 12; 30(5):. PubMed ID: 39239747
    [Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines.
    Dokduang H, Jamnongkarn W, Promraksa B, Suksawat M, Padthaisong S, Thanee M, Phetcharaburanin J, Namwat N, Sangkhamanon S, Titapun A, Khuntikeo N, Klanrit P, Loilome W.
    Drug Des Devel Ther; 2020 Nov 12; 14():2319-2334. PubMed ID: 32606601
    [Abstract] [Full Text] [Related]

  • 8. Leptin stimulates the epithelial‑mesenchymal transition and pro‑angiogenic capability of cholangiocarcinoma cells through the miR‑122/PKM2 axis.
    Peng C, Sun Z, Li O, Guo C, Yi W, Tan Z, Jiang B.
    Int J Oncol; 2019 Jul 12; 55(1):298-308. PubMed ID: 31115511
    [Abstract] [Full Text] [Related]

  • 9. Shikonin exerts antitumor activity by causing mitochondrial dysfunction in hepatocellular carcinoma through PKM2-AMPK-PGC1α signaling pathway.
    Liu B, Jin J, Zhang Z, Zuo L, Jiang M, Xie C.
    Biochem Cell Biol; 2019 Aug 12; 97(4):397-405. PubMed ID: 30475643
    [Abstract] [Full Text] [Related]

  • 10. Shikonin differentially regulates glucose metabolism via PKM2 and HIF1α to overcome apoptosis in a refractory HCC cell line.
    Yang W, Liu J, Hou L, Chen Q, Liu Y.
    Life Sci; 2021 Jan 15; 265():118796. PubMed ID: 33220292
    [Abstract] [Full Text] [Related]

  • 11. Metformin Exerts Antiproliferative and Anti-metastatic Effects Against Cholangiocarcinoma Cells by Targeting STAT3 and NF-ĸB.
    Saengboonmee C, Seubwai W, Cha'on U, Sawanyawisuth K, Wongkham S, Wongkham C.
    Anticancer Res; 2017 Jan 15; 37(1):115-123. PubMed ID: 28011481
    [Abstract] [Full Text] [Related]

  • 12. Novel Adiponectin Receptor Agonist Inhibits Cholangiocarcinoma via Adenosine Monophosphate-activated Protein Kinase.
    Bui KC, Nguyen TML, Barat S, Scholta T, Xing J, Bhuria V, Sipos B, Wilkens L, Nguyen LT, Le HS, Velavan TP, Bozko P, Plentz RR.
    Curr Med Chem; 2024 Jan 15; 31(28):4534-4548. PubMed ID: 38361349
    [Abstract] [Full Text] [Related]

  • 13. Artesunate and chloroquine induce cytotoxic activity on cholangiocarcinoma cells via different cell death mechanisms.
    Guragain D, Seubwai W, Kobayashi D, Silsinivanit A, Vaeteewoottacharn K, Sawanyawisuth K, Wongkham C, Wongkham S, Araki N, Cha'on U.
    Cell Mol Biol (Noisy-le-grand); 2018 Jul 30; 64(10):113-118. PubMed ID: 30084802
    [Abstract] [Full Text] [Related]

  • 14. Shikonin Suppresses Skin Carcinogenesis via Inhibiting Cell Proliferation.
    Li W, Zhang C, Ren A, Li T, Jin R, Li G, Gu X, Shi R, Zhao Y.
    PLoS One; 2015 Jul 30; 10(5):e0126459. PubMed ID: 25961580
    [Abstract] [Full Text] [Related]

  • 15. Cordycepin Inhibits Cancer Cell Proliferation and Angiogenesis through a DEK Interaction via ERK Signaling in Cholangiocarcinoma.
    Liu T, Zhu G, Yan W, Lv Y, Wang X, Jin G, Cui M, Lin Z, Ren X.
    J Pharmacol Exp Ther; 2020 May 30; 373(2):279-289. PubMed ID: 32102917
    [Abstract] [Full Text] [Related]

  • 16. Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma.
    Hu MH, Huang TT, Chao TI, Chen LJ, Chen YL, Tsai MH, Liu CY, Kao JH, Chen KF.
    Liver Int; 2018 Dec 30; 38(12):2248-2259. PubMed ID: 29797403
    [Abstract] [Full Text] [Related]

  • 17. Curcumin-mediated regulation of Notch1/hairy and enhancer of split-1/survivin: molecular targeting in cholangiocarcinoma.
    Koprowski S, Sokolowski K, Kunnimalaiyaan S, Gamblin TC, Kunnimalaiyaan M.
    J Surg Res; 2015 Oct 30; 198(2):434-40. PubMed ID: 25890434
    [Abstract] [Full Text] [Related]

  • 18. Quantitative proteomics analysis reveals possible anticancer mechanisms of 5'-deoxy-5'-methylthioadenosine in cholangiocarcinoma cells.
    Kerdkumthong K, Nanarong S, Roytrakul S, Pitakpornpreecha T, Tantimetta P, Runsaeng P, Obchoei S.
    PLoS One; 2024 Oct 30; 19(6):e0306060. PubMed ID: 38923999
    [Abstract] [Full Text] [Related]

  • 19. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H, Zhang J, Zhang Y, Feng Q, Wang H, Li G, Jiang W, Li X.
    Gene; 2019 May 25; 698():50-60. PubMed ID: 30822475
    [Abstract] [Full Text] [Related]

  • 20. Allicin Inhibits Proliferation and Invasion in Vitro and in Vivo via SHP-1-Mediated STAT3 Signaling in Cholangiocarcinoma.
    Chen H, Zhu B, Zhao L, Liu Y, Zhao F, Feng J, Jin Y, Sun J, Geng R, Wei Y.
    Cell Physiol Biochem; 2018 May 25; 47(2):641-653. PubMed ID: 29794468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.